ESCALON MEDICAL CORP (ESMC) Form 10-Q — May 15, 2026
Escalon Medical Corp. reported net income of $2.2 million for the nine months ended March 31, 2026, driven primarily by a $2.8 million non-recurring gain from the sale of its AXIS software assets to Optos Public Limited Company. Without this asset sale, the company would have reported an operating loss of $523,000 for the period, highlighting underlying operational challenges. Revenue declined 6.3% year-over-year to $8.9 million, attributed to backorders in Sonomed products and lower order volume for Trek products.
Key figures
- Eps
- 0.15
- Revenue
- 8875291
- Net Income
- 2231261
- Total Debt
- 139764
- Total Assets
- 7532271
- Cash Position
- 3342537
- Working Capital
- 4034000
- Asset Sale Proceeds
- 3000000
- Gain From Asset Sale
- 2813525
Price after filing
Close on the filing date to close N calendar days later (from $0.25). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.